|
Market Closed -
Nasdaq Stockholm
09:30:00 16/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1.900 SEK | +11.76% |
|
+11.44% | - |
| 02/09 | Enzymatica CEO buys additional shares | FW |
| 01/09 | Enzymatica CEO buys 33 384 shares | FW |
| Market Cap | 46Cr 41Cr 38Cr 35Cr 65Cr 4.38TCr 66Cr 456.74Cr 179.08Cr 2.28TCr 173.09Cr 169.4Cr 7.28TCr | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 43Cr 38Cr 35Cr 32Cr 61Cr 4.07TCr 62Cr 424.94Cr 166.61Cr 2.13TCr 161.04Cr 157.61Cr 6.77TCr | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ENZY | Delayed | |
Deutsche Boerse AG
| EN9 | Delayed | |
|
Börse Stuttgart
| EN9 | Delayed | |
|
Boerse Muenchen
| EN9 | Real-time |
| 1 day | +11.76% | ||
| 1 week | +11.44% | ||
| Current month | +11.11% | ||
| 1 month | +2.70% | ||
| 3 months | -12.84% | ||
| 6 months | -32.86% |
| 1 week | 1.67 |  | 2 |
| 1 month | 1.55 | | 2 |
| Current year | 1.55 | | 3.4 |
| 1 year | 1.55 | | 3.4 |
| 3 years | 1.34 | | 5.45 |
| 5 years | 1.34 | | 12 |
| 10 years | 1.34 | | 24.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 01/02/2026 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 13/04/2026 |
| Chief Tech/Sci/R&D Officer | - | 27/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 01/05/2026 | |
Bengt Baron
CHM | Chairman | 64 | 19/12/2016 |
| Chairman | 58 | 15/02/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/07/26 | Buy | Chief Financial Officer | 50,000 | 0.0206% | ||
| 01/04/26 | Sell | Responsable ventes & marketing | 40,000 | 0.0165% | ||
| 30/12/25 | Buy | Chairman | 20,000 | 0.0082% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +11.76% | +11.44% | -7.77% | -48.65% | 4.66Cr | |
| +0.43% | +6.59% | +53.41% | +103.85% | 1,12000Cr | |
| +0.90% | -2.25% | +33.02% | +62.23% | 62TCr | |
| +0.71% | +3.24% | +25.81% | +93.86% | 50TCr | |
| -0.13% | +5.98% | +32.91% | +50.39% | 37TCr | |
| +0.52% | +0.24% | +73.92% | +40.15% | 36TCr | |
| -0.95% | +4.70% | +19.51% | +43.00% | 29TCr | |
| -1.98% | +3.73% | -0.86% | +13.43% | 26TCr | |
| -0.35% | +4.25% | +46.21% | +50.76% | 23TCr | |
| -0.75% | +3.32% | +32.53% | +97.21% | 19TCr | |
| Average | +1.02% | +4.40% | +30.87% | +50.62% | 39.41TCr | |
| Weighted average by Cap. | +0.13% | +3.83% | +39.18% | +71.43% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.56Cr 4.05Cr 3.75Cr 3.42Cr 6.45Cr 432.54Cr 6.55Cr 45Cr 18Cr 225.72Cr 17Cr 17Cr 719.55Cr | 5.39Cr 4.79Cr 4.44Cr 4.04Cr 7.62Cr 511.58Cr 7.75Cr 53Cr 21Cr 266.96Cr 20Cr 20Cr 851.04Cr |
| Net income | -5.32Cr -4.73Cr -4.38Cr -3.99Cr -7.52Cr -504.71Cr -7.64Cr -53Cr -21Cr -263.38Cr -20Cr -20Cr -839.61Cr | -5.19Cr -4.61Cr -4.28Cr -3.89Cr -7.34Cr -492.47Cr -7.46Cr -51Cr -20Cr -256.99Cr -19Cr -19Cr -819.25Cr |
| Net Debt | -7.3Cr -6.49Cr -6.02Cr -5.47Cr -10Cr -692.93Cr -10Cr -72Cr -28Cr -361.6Cr -27Cr -27Cr -1.15TCr | -3.21Cr -2.85Cr -2.65Cr -2.41Cr -4.54Cr -304.76Cr -4.61Cr -32Cr -12Cr -159.03Cr -12Cr -12Cr -506.98Cr |
Employees
18
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | SEK 1.900 | +11.76% | 1,91,284 |
| 15/26/15 | SEK 1.700 | -3.41% | 46,271 |
| 14/26/14 | SEK 1.760 | +3.53% | 99,076 |
| 13/26/13 | SEK 1.700 | -3.95% | 4,40,245 |
| 12/26/12 | SEK 1.770 | +3.81% | 2,46,346 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- ENZY Stock
Select your edition
All financial news and data tailored to specific country editions
